BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15355929)

  • 1. In vitro toxicity of A-431 carcinoma cells with antibodies to epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to radionuclides emitting low-energy electrons.
    Michel RB; Castillo ME; Andrews PM; Mattes MJ
    Clin Cancer Res; 2004 Sep; 10(17):5957-66. PubMed ID: 15355929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of 4 radionuclides conjugated to antibodies for single-cell kill.
    Michel RB; Brechbiel MW; Mattes MJ
    J Nucl Med; 2003 Apr; 44(4):632-40. PubMed ID: 12679410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
    Govindan SV; Goldenberg DM; Elsamra SE; Griffiths GL; Ong GL; Brechbiel MW; Burton J; Sgouros G; Mattes MJ
    J Nucl Med; 2000 Dec; 41(12):2089-97. PubMed ID: 11138697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons.
    Michel RB; Rosario AV; Andrews PM; Goldenberg DM; Mattes MJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):777-86. PubMed ID: 15701868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell cytotoxicity with radiolabeled antibodies.
    Ong GL; Elsamra SE; Goldenberg DM; Mattes MJ
    Clin Cancer Res; 2001 Jan; 7(1):192-201. PubMed ID: 11205908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.
    Michel RB; Andrews PM; Rosario AV; Goldenberg DM; Mattes MJ
    Nucl Med Biol; 2005 Apr; 32(3):269-78. PubMed ID: 15820762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium.
    Ochakovskaya R; Osorio L; Goldenberg DM; Mattes MJ
    Clin Cancer Res; 2001 Jun; 7(6):1505-10. PubMed ID: 11410483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
    Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
    J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons.
    Pouget JP; Santoro L; Raymond L; Chouin N; Bardiès M; Bascoul-Mollevi C; Huguet H; Azria D; Kotzki PO; Pèlegrin M; Vivès E; Pèlegrin A
    Radiat Res; 2008 Aug; 170(2):192-200. PubMed ID: 18666820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies.
    Griffiths GL; Govindan SV; Sgouros G; Ong GL; Goldenberg DM; Mattes MJ
    Int J Cancer; 1999 Jun; 81(6):985-92. PubMed ID: 10362149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionuclide-antibody conjugates for single-cell cytotoxicity.
    Mattes MJ
    Cancer; 2002 Feb; 94(4 Suppl):1215-23. PubMed ID: 11877748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose.
    DeSombre ER; Shafii B; Hanson RN; Kuivanen PC; Hughes A
    Cancer Res; 1992 Oct; 52(20):5752-8. PubMed ID: 1394199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient mutation induction by 125I and 131I decays in DNA of human cells.
    Whaley JM; Little JB
    Radiat Res; 1990 Jul; 123(1):68-74. PubMed ID: 2371380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
    Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
    J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry and risk from low- versus high-LET radiation of Auger events and the role of nuclide carriers.
    Feinendegen LE; Neumann RD
    Int J Radiat Biol; 2004; 80(11-12):813-22. PubMed ID: 15764388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc.
    Kriehuber R; Kadenbach K; Schultz F; Weiss DG
    Int J Radiat Biol; 2004; 80(11-12):875-80. PubMed ID: 15764396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles.
    El-Sayed IH; Huang X; El-Sayed MA
    Cancer Lett; 2006 Jul; 239(1):129-35. PubMed ID: 16198049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody.
    Daghighian F; Barendswaard E; Welt S; Humm J; Scott A; Willingham MC; McGuffie E; Old LJ; Larson SM
    J Nucl Med; 1996 Jun; 37(6):1052-7. PubMed ID: 8683300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
    Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
    J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [99mTc reduces clonogenic survival after intracellular uptake in NIS-positive cells in vitro more than 131I].
    Wendisch M; Freudenberg R; Drechsel J; Runge R; Wunderlich G; Kotzerke J
    Nuklearmedizin; 2010; 49(4):154-60. PubMed ID: 20490428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.